Immune responses of cattle to African trypanosomes: Protective or pathogenic?

International Journal for Parasitology

Volumn 28, Issue 2, 1998, Pages 219-240

  Taylor, Katherine A ^a  

^a INTERNATIONAL LIVESTOCK RESEARCH INSTITUTE   (Kenya)

Author keywords

Antibody; Bovine; Complement; Immunodepressio n; Isotype; T cell; Trypanosoma congolense; Trypanosomosis; Trypanosusceptible; Trypanotolerant

Indexed keywords

AUTOANTIBODY; COMPLEMENT RECEPTOR; FC RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 2;

ANIMAL MODEL; CATTLE DISEASE; COMPLEMENT ACTIVATION; HOST PARASITE INTERACTION; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; NONHUMAN; PROTOZOAL INFECTION; REVIEW; T LYMPHOCYTE ACTIVATION; TRYPANOSOMA CONGOLENSE; TRYPANOSOMIASIS;

ANIMALS; CATTLE; CATTLE DISEASES; DISEASE SUSCEPTIBILITY; IMMUNITY, NATURAL; TRYPANOSOMA CONGOLENSE; TRYPANOSOMIASIS, AFRICAN; VARIANT SURFACE GLYCOPROTEINS, TRYPANOSOMA;

ANIMALIA; BOS TAURUS; BOVINAE; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CONGOLENSE;

EID: 0032005105     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(97)00154-9     Document Type: Review

References (224)

1. [1] Bruce D. Preliminary report on the tsetse fly disease of nagana, in Zululand. Durban: Bennet & Davis, 1895;28 (taken from Cook, 1994 [3]).
2. [2] Bruce D. Further Report on the tsetse fly disease or nagana, in Zululand, London: Harrison 1896;69 (taken from Cook, 1994 [3]).
3. [3] Cook GC. Sir David Bruce's elucidation of the aetiology of nagana - exactly one hundred years ago. Trans R Soc Trop Med Hyg 1994;88:257-258.
4. [4] Plimmer HG, Bradford JR. A preliminary note on the morphology and distribution of the organism found in the tsetse fly disease. Proc R Soc Lond 1899;65:274-281 (taken from Cook, 1994 [3]).
5. [5] Hursey BS, Slingenbergh J. The tsetse fly and its effects on agriculture in sub-Saharan Africa. World Anim Rev 1995; 3-4:67-73.
6. [6] Otte MJ, Abuabara JY, Wells EA. Trypanosoma vivax in Colombia: epidemiology and production losses. Trop Anim Health Prod 1994;26:146-156.
7. [7] Baumann MP, Zessin KH. Productivity and health of camels (Camelus dromedarius) in Somalia: associations with trypanosomosis and brucellosis. Trop Anim Health Prod 1992;24:145-156.
8. [8] Franke CR, Greiner M, Mehlitz D. Investigations on naturally occurring Trypanosoma evansi infections in horses, cattle, dogs and capybaras (Hydrochaeris hydrochaeris) in Pantanal de Pocone (Mato Grosso, Brazil). Acta Trop 1994;58:159-169.
9. [9] Payne RC, Sukanto IP, Djauhari D, et al. Trypanosoma evansi infection in cattle, buffaloes and horses in Indonesia. Vet Parasitol 1991;38:109-119.
10. [10] Holmes PH, Scott JM. Chemotherapy against animal trypanosomiasis. In: Baker JR, editor. Perspectives in trypanosomiasis research. Chichester: Research Studies Press, John Wiley, 1982;59-69.
11. [11] Dransfield RD, Brightwell R, Kyorku C, Williams B. Control of tsetse fly (Diptera: Glossinidae) populations using traps at Nguruman, south-west Kenya. Bull Entomol Res 1990;80:265-276.
12. [12] Borst P, Rudenko G. Antigenic variation in African trypanosomes. Science 1994;264:1872-1873.
13. [13] Duxbury RE, Anderson JS, Wellde BT, Sadun EH, Muriithi IE. Trypanosoma congolense: immunisation of mice, dogs and cattle with gamma-irradiated parasites. Exp Parasitol 1972;32:527-533.
14. [14] Wellde BT, Schoenbeckler MJ, Diggs CL, Langbelin HR, Sadun EH. Trypanosoma rhodesiense: variant specificity of immunity induced by irradiated parasites. Exp Parasitol 1975;37:125-129.
15. [15] Morrison WI, Black SJ, Paris J, Hinson CA, Wells PW. Protective immunity and specificity of antibody responses elicited in cattle by irradiated Trypanosoma brucei. Parasite Immunol 1982;4:395-407.
16. [16] Wells PW, Emery DL, Hinson CA, Morrison WI, Murray M. Immunisation of cattle with variant-specific surface antigen of Trypanosoma brucei: the influence of different adjuvants. Infect Immun 1982;36:1-10.
17. [17] Mkunza F, Olaho WM, Powell CN. Partial protection against natural trypanosomiasis after vaccination with a flagellar pocket antigen from Trypanosoma brucei rhodesiense. Vaccine 1995;13:151-154.
18. [18] Mulla AF, Rickman LR. How do African game animals control trypanosome infection. Parasitol Today 1988;4:352-354.
19. [19] Murray M, Morrison WI, Murray PK, Clifford DJ, Trail JCM. Trypanotolerance - a review. World Anim Rev 1979;31:2-12.
20. [20] Murray M, Morrison WI, Whitelaw DD. Host susceptibility to African trypanosomiasis: trypanotolerance. Adv Parasitol 1982;1:1-68.
21. [21] Paling RW, Moloo SK, Scott JR, et al. Susceptibility of N'Dama and Boran cattle to tsetse-transmitted primary and rechallenge infections with a homologous serodeme of Trypanosoma congolense. Parasite Immunol 1991;13:413-425.
22. [22] Paling RW, Moloo SK, Scott JR, Gettinby G, McOdimba FA, Murray M. Susceptibility of N'Dama and Boran cattle to sequential challenges with tsetse-transmitted clones of Trypanosoma congolense. Parasite Immunol 1991;13:427-445.
23. [23] Saror DI, Ilemobade AA, Nuru S. The haematology of N'Dama and Zebu cattle experimentally infected with Trypanosoma vivax. In: OAU/STRC, editor. Proceedings of the 16th Meeting of the International Scientific Council for the Trypanosomiasis Research and Control, Yaounde, Cameroon. Nairobi: Eleza Services, 1979;287-294.
24. [24] Williams DJL, Logan-Henfrey LL, Authié E, Seely C, McOdimba F. Experimental infection with a haemorrhage-causing Trypanosoma vivax in N'Dama and Boran cattle. Scand J Immunol 1992;36:34-36.
25. [25] Hudson KM, Byner C, Freeman J, Terry RJ. Immunodepression, high IgM levels and evasion of the immune response in murine trypanosomiasis. Nature (Lond) 1976; 264:256-258.
26. [26] Luckins AG, Mehlitz D. Observations on serum immunoglobulin levels in cattle infected with Trypanosoma brucei, T. vivax, and T. congolense. Ann Trop Med Parasitol 1976;70:479-480.
27. [27] Mayor-Whithey KS, Clayton CE, Roelants GE, Askonas BA. Trypanosomiasis leads to extensive proliferation of B-, T-and null cells in spleen and bone marrow. Clin Exp Immunol 1978;34:359-363.
28. [28] Morrison WI, Roelants GE, Mayor-Withey KS, Murray M. Susceptibility of inbred strains of mice to Trypanosoma congolense: correlation with changes in spleen lymphocyte populations. Clin Exp Immunol 1978;32:25-40.
29. [29] Morrison WI, Murray M. Lymphoid changes in African trypanosomiasis. In: Losos G, Chouinard A, editors. Pathogenicity of Trypanosomes. Ottowa: International Development Research Center, 1979;154.
30. [30] Ellis JA, Scott JR, MacHugh ND, Gettinby G, Davis WC. Peripheral blood leukocytes subpopulation dynamics during Trypanosoma congolense infection in Boran and N'Dama cattle: an analysis using monoclonal antibodies and flow cytometry. Parasite Immunol 1987;9:363-378.
31. [31] Askonas BA, Corsini AC, Clayton CE, Ogilvie BM. Functional depletion of T-and B-memory cells and other lymphoid cell subpopulations during trypanosomiasis. Immunology 1979;36:313-321.
32. [32] Kobayakawa T, Louis J, Izui S, Lambert PH. Autoimmune responses to DNA, red blood cells, and thymocyte antigens in association with polyclonal antibody synthesis during experimental African trypanosomiasis. J Immunol 1979; 122: 296-301.
33. [33] Williams DJL, Taylor KA, Newson J, Gichuki B. The role of anti-variable surface glycoprotein antibody responses in bovine trypanotolerance. Parasite Immunol 1996;18:209-218.
34. 75Se-labelled Trypanosoma brucei in mice. II. Mechanisms in immune animals. Immunology 1980;40:629-635.
35. 75Se-labelled Trypanosoma brucei in goats. Acta Trop 1989;46:101-106.
36. [36] Dempsey WL, Mansfield JM. Lymphocyte function in experimental African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte system in variant-specific immunity. J Immunol 1983;130:405-411.
37. [37] Levine RF, Mansfield JM. Genetics of resistance to the African trypanosomes III. Variant-specific antibody responses of H-2 compatible resistant and susceptible mice. J Immunol 1984;133:1564-1569.
38. [38] DeGee ALW, Shah SP, Doyle JJ. Trypanosoma vivax: the courses of infection with three stabilates in inbred strains of mice. Exp Parasitol 1982;54:33-39.
39. [39] Mahan SM, Hendershot L, Black SJ. Control of trypanodestructive antibody responses and parasitemia in mice infected with Trypanosoma (Dutttonella) vivax. Infect Immun 1986;54:213-221.
40. [40] MacAskill JA, Holmes PH, Whitelaw DD, Jennings FW, Urquhart GM. Immune mechanisms in C57B1 mice genetically resistant to Trypanosoma congolense infection. II. Aspects of humoral response. Parasite Immunol 1983;5:577-586.
41. [41] Whitelaw DD, MacAskill JA, Holmes PH, Jennings FW, Urquhart GM. Immune mechanisms in C57B1 mice genetically resistant to Trypanosoma congolense infection. I. Effects of immune modulation. Parasite Immunol 1983;5:85-94.
42. [42] Mitchell LA, Pearson TW. Antibody responses in resistant and susceptible inbred mice infected with Trypanosoma congolense. Immunology 1986;57:297-303.
43. [43] Black SJ, Sendashonga CN, Webster P, Koch GLE, Shapiro SZ. Regulation of parasite-specific antibody responses in resistant (C57B1/6) and susceptible (C3H/HE) mice infected with Trypanosoma (trypanozoon) brucei brucei. Parasite Immunol 1986;8:425-442.
44. [44] Takayanagi T, Nakatake Y, Enriquez GL. Trypanosoma gambiense phagocytosis in vitro. Exp Parasitol 1974;36:106-113.
45. [45] Ngaira JM, Nantulya VM, Musoke AJ, Hirumi K. Phagocytosis of antibody-sensitized Trypanosoma brucei in vitro by bovine peripheral blood monocytes. Immunology 1983;49:393-400.
46. [46] Chandler RL. Studies on the tolerance of N'Dama cattle to trypanosomiasis. J Comp Pathol 1958;68:253-260.
47. [47] Dwinger RH, Clifford DJ, Agyemang K, et al. Comparative studies on N'Dama and zebu cattle following repeated infection with Trypanosoma congolense. Res Vet Sci 1992;52:292-298.
48. [48] Pinder M, Libaeu G, Hirsch W, Tamboura I, Hauck-Bauer R, Roelants GE. Anti-trypanosome specific immune responses in bovids of differing susceptibility to African trypanosomiasis. Immunology 1984;51:247-258.
49. [49] Pinder M, Bauer J, Melick A, Fumoux F. Immune responses of trypanoresistant and trypanosusceptible cattle after cyclical infection with Trypanosoma congolense. Vet Immunol Immunopathol 1988;18:245-257.
50. [50] Akol GWO, Authié E, Pinder M, Moloo SK, Roelants GE, Murray M. Susceptibility and immune responses of Zebu and Taurine cattle of West Africa to infection with Trypanosoma congolense transmitted by Glossina morsitans centralis. Vet Immunol Immunopathol 1986;11:361-373.
51. [51] Taylor KA, Lutje V, Kennedy D, et al. Trypanosoma congolense: B-lymphocyte responses differ between trypanotolerant and trypanosusceptible cattle. Exp Parasitol 1996;83:106-116.
52. [52] Nielsen K, Sheppard J, Holmes W, Tizard I. Experimental bovine trypanosomiasis changes in serum immunoglobulins, complement, and complement components in infected animals. Immunology 1978;35:817-826.
53. [53] Nielsen K, Sheppard J, Holmes W, Tizard I. Experimental bovine trypanosomiasis. Changes in the catabolism of serum immunoglobulins and complement components in infected cattle. Immunology 1978;35:811-816.
54. [54] Banks KL. Binding of Trypanosoma congolense to the walls of small blood vessels. J Protozool 1978;25:241-245.
55. [55] Masake RA, Morrison WI. Evaluation of the structural and functional changes in the lymphoid organs of Boran cattle infected with Trypanosoma vivax. Am J Vet Res 1981;42:1738-1746.
56. [56] Whitelaw DD, Gardiner PR, Murray M. Extravascular foci of Trypanosoma vivax in goats: the central nervous system and aqueous humor of the eye as potential sources of relapse infection after chemotherapy. Parasitology 1988;97:51-61.
57. [57] Ikede BO, Losos GJ. Pathological changes in cattle infected with Trypanosoma brucei. Vet Pathol 1972;9:272-277.
58. [58] Whitelaw DD, Moulton JE, Morrison WI, Murray M. Central nervous system involvement in goats undergoing primary infections with Trypanosoma brucei and relapse infections after chemotherapy. Parasitology 1985;90:255-268.
59. [59] Maxie MG, Losos GJ. Effect of Berenil on Trypanosoma congolense and Trypanosoma vivax in cattle blood. In: OAU/STRC, editor. Proceedings of the 15th Meeting of the International Scientific Council for Trypanosomiasis Research and Control, The Gambia. Nairobi: Eleza Services, 1977;413-417.
60. [60] Majiwa PAO, Thatthi R, Moloo SK, Nyeko JHP, Otieno LH, Maloo S. Detection of trypanosome infections in the saliva of tsetse flies and buffy coat samples from anti-genaemic but aparasitaemic cattle. Parasitology 1994;108: 313-322.
61. [61] Authié E, Muteti DK, Mbawa ZR, Lonsdale-Eccles JD, Webster P, Wells CW. Identification of a 33-kilodalton immunodominant antigen of Trypanosoma congolense as a cysteine protease. Mol Biochem Parasitol 1992;56:103-116.
62. [62] Authié E, Duvallet G, Roberson C, Williams DJL. Antibody responses to a 33 kDa cysteine protease of Trypanosoma congolense: relationship to "trypanotolerance" in cattle. Parasite Immunol 1993;15:465-474.
63. [63] Authié E, Muteti DK, Williams DJL. Antibody responses to invariant antigens of Trypanosoma congolense in cattle of differing susceptibility to trypanosomiasis. Parasite Immunol 1993;15:101-111.
64. [64] Boulangé A, Authié E. A 69 kDa immunodominant antigen of Trypanosoma (Nannomonas) congolense is homologous to immunoglobulin heavy chain binding protein (BiP). Parasitology 1994;109:163-173.
65. [65] Authié E. Trypanosomiasis and trypanotolerance in cattle: a role for congopain?. Parasitol Today 1994;10:360-364.
66. [66] Diffley P, Strickler JE, Patton CL, Waksman BH. Detection and quantification of variant-specific antigen in the plasma of rats and mice infected with Trypanosoma brucei brucei. J Parasitol 1980;66:185-191.
67. [67] Diffley P. Trypanosmal surface coat variant antigen causes polyclonal lymphocyte activation. J Immunol 1983; 131: 1983-1986.
68. [68] Diffley P. Mice varying in resistance to African trypanosomiasis respond differently to treatments with variant surface glycoprotein. Eur J Immunol 1985;15:321-324.
69. [69] Esievo KAN. In vitro production of neuraminidase (sialidase) by Trypanosoma vivax. In: OAU/STRC, edstor. Proceedings of the 16th Meeting of International Scientific council for Trypanosomiasis Research and Control, Yaounde, Cameroun. Nairobi: Eleza Services, 1979;205-210.
70. [70] Esievo KAN, Saror DI, Ilemobade AA, Hallway MH. Variation in erythrocyte surface and free serum sialic acid concentrations during experimental Trypanosoma vivax infections in cattle. Res Vet Sci 1982;32:1-5.
71. [71] Esievo KAN, Saror DI, Kolo MN, Eduvie LO. Erythrocytes surface sialic acid in N'Dama and Zebu cattle. J Comp Pathol 1986;96:95-99.
72. [72] Esievo KAN, Jaye A, Andrews JN, et al. Electrophoresis of bovine erythrocyte sialic acids: existence of additional bands in trypanotolerant N'Dama cattle. J Comp Pathol 1990;102:357-361.
73. [73] Magez S, Lucas R, Darji A, Songa EB, Hamers R, De Baetselier P. Murine tumour necrosis factor plays a protective role during the initial phase of the experimental infection with Trypanosoma brucei brucei. Parasite Immunol 1993;15:635-641.
74. [74] Bakhiet M, Olsson T, Edlund C, et al. A Trypanosoma brucei brucei-derived factor that triggers CD8+ lymphocytes to interferon-gamma secretion: purification, characterization and protective effects in vivo by treatment with a monoclonal antibody against the factor. Scand J Immunol 1993;37:166-178.
75. [75] Darji A, Sileghem M, Heremans H, Brys L, De Baetselier P. Inhibition of T-cell responsiveness during experimental infections with Trypanosoma brucei: active involvement of endogenous gamma interferon. Infect Immun 1993;61:3098-3102.
76. [76] Sztein MB, Kierszenbaum F. A soluble factor from Trypanosoma brucei rhodesiense that prevents progression of activated human T lymphocytes through the cell cycle. Immunology 1991;73:180-185.
77. [77] Nielsen K, Sheppard J, Tizard I, Holmes W. Direct activation of complement by trypanosomes. J Parasitol 1978;64:544-546.
78. [78] Musoke AJ, Barbet AF. Activation of complement by variant-specific surface antigen of Trypanosoma brucei. Nature (Lond) 1977;270:438-440.
79. [79] Huan CN, Webb L, Lambert PH, Miescher PA. Pathogenesis of the anemia in African trypanosomiasis: characterization and purification of a hemolytic factor. Schweiz Med Wochenschr 1975;105:1582-1583.
80. [80] Murray M, Huan CN, Lambert PH, Gerber H. The anaemia of African trypanosomiasis. Demonstration of a haemolytic factor. In: OAU/STRC, editor. Proceedings of the 15th Meeting of the International Scientific Council for Trypanosomiasis Research and Control, The Gambia. Nairobi: Eleza Services, 1977;460-469.
81. [81] Tizard IR, Holmes WL, York DA, Mellors A. The generation and identification of the hemolysin of Trypanosoma congolense. Experientia 1977;33:901-902.
82. [82] Shapiro SZ, Murray M. African trypanosome antigens recognized during the course of infection in N'Dama and Zebu cattle. Infect Immun 1982;35:410-416.
83. [83] Logan-Henfrey LL, Gardiner PR, Mahmoud MM. Animal trypanosomiasis in sub-Saharan Africa. In: Kreier JP, Baker JR, editors. Parasitic protozoa, Vol. 2. San Diego, CA: Academic Press, 1992;157-275.
84. [84] Dargie JC, Murray PK, Murray M, Grimshaw WTR, McIntyre WIM. Bovine trypanosomiasis: the red cell kinetics of N'Dama and Zebu cattle infected with Trypanosoma congolense. Parasitology 1979;78:271-286.
85. [85] Andrianarivo AG, Muiya P, Opollo M, Logan-Henfrey LL. Trypanosoma congolense: comparative effects of a primary infection on bone marrow progenitor cells from N'Dama and Boran cattle. Exp Parasitol 1995;80:407-418.
86. [86] Rickman WJ, Cox HW. Association of autoantibodies with anemia, splenomegaly, and glomerulonephritis in experimental African trypanosomiasis. J Parasitol 1979;65:65-73.
87. [87] Rickman WJ, Cox HW. Trypanosome antigen-antibody complexes and immunoconglutinin interaction in African trypanosomiasis. Int J Parasitol 1983;13:389-392.
88. [88] Lonsdale-Eccles JD, Grab D. Proteases in African trypanosomes. In: Turk V, editor. Cysteine proteinases and their inhibitors. Berlin: Walter de Gruyter, 1986;189-197.
89. [89] Mellors A Phospholipases in trypanosomes. In: Tizard I, editor. Immunology and pathogenesis of trypanosomiasis. Boca Raton, FL: CRC Press, 1985;67-74.
90. [90] Esievo KAN. Trypanosoma vivax, stock V953: inhibitory effect of Type A influenza virus anti-HAV8 serum on in vitro neuraminidase (sialidase) activity. J Parasitol 1983;69:491-495.
91. [91] Assoku RKG, Gardiner PR. Detection of antibodies to platelets and erythrocytes during haemorrhagic Trypanosoma vivax infection of Aryshire cattle. Vet Parasitol 1989;31:199-216.
92. [92] Müller N, Mansfield JM, Seebeck T. Trypanosome variant surface glycoproteins are recognized by self-reactive antibodies in uninfected hosts. Infect Immun 1996;64:4593-4597.
93. [93] Schneider A, Lutz HU, Marugg R, Gehr P, Seebeck T. Spectrin-like proteins in the paraflagellar rod structure of Trypanosoma brucei. J Cell Sci 1988;90:307-315.
94. [94] Woods A, Sherwin T, Sasse R, MacRac TH, Baines AJ, Gull K. Definition of individual components within the cytoskeleton of Trypanosoma brucei by a library of monoclonal antibodies. J Cell Sci 1989;93:491-500.
95. [95] Musoke AJ, Nantulya VM, Barbet AF, Kironde F, McGuire TC. Bovine immune responses to African trypanosomes: specific antibodies to variable surface glycoproteins of Trypanosoma brucei. Par Immunol 1981;3:97-106.
96. [96] Tabel H, Losos GJ, Maxie MG, Minder CE. Experimental bovine trypanosomiasis (Trypanosoma vivax and T. congolense). III. Serum levels of immunoglobulins, heterophile antibodies, and antibodies to T. vivax. Tropenmed Parasitol 1981;32:149-153.
97. [97] MacKenzie AR, Boreham PFL, Facer CA. Autoantibodies in African trypanosomiasis. Trans R Soc Trop Med Hyg 1973;67:268.
98. 2 and of antigen concentration on prozoning in the complement fixation test for bovine brucellosis. Res Vet Sci 1977;22:194-197.
99. [99] Seed JR. Antigen and antigenic variability of the African trypanosomes. J Protozool 1974;21:639-646.
100. [100] Diffley P, Honigberg BM. Immunologic analysis of host plasma proteins on bloodstream forms of African trypanosomes. II. Identification and quantitation of surface-bound albumin, non-specific IgG, and complement on Trypanosoma congolense. J Parasitol 1978;64:674-681.
101. [101] Stevens DR, Moulton JE. Ultrastructural and immunological aspects of the phagocytosis of Trypanosoma brucei by mouse peritoneal macrophages. Infect Immun 1978; 19:972-982.
102. [102] Takayanagi T, Kawaguchi H, Yabu Y, Itoh M, Appauy MA. Contribution of the complement system to antibody-mediated binding of Trypanosoma gambiense to macrophages. J Parasitol 1987;73:333-341.
103. [103] Vickerman K. Antigenic variation in trypanosomes. Nature (Lond) 1978;322:613-617.
104. [104] Greenwood BM, Whittle HC. The pathogenesis of sleeping sickness. Trans R Soc Trop Med Hyg 1980;74:716-725.
105. [105] Devine DV, Falk RJ, Balber AE. Restriction of the alternative pathway of human complement by intact Trypanosoma brucei subsp. gambiense. Infect Immun 1986; 52:223-229.
106. [106] Nielsen K. Complement in trypanosomiasis. In: Tizard I, editor. Immunology and pathogenesis of trypanosomiasis. Boca Raton, FL: CRC Press, 1985;133-144.
107. [107] Authié E, Pobel T. Serum haemolytic complement activity and C3 levels in bovine trypanosomiasis under natural conditions of challenge - early indications of individual susceptibility to disease. Vet Parasitol 1990;35:43-59.
108. [108] Otesile EB, Lee M, Tabel H. Plasma levels of proteins of the alternative complement pathway in inbred mice that differ in resistance to Trypanosoma congolense infections. J Parasitol 1991;77:958-964.
109. [109] Böttger EC, Bitter-Suermann D. Complement and the regulation of the humoral immune responses. Immunol Today 1987;8:261-264.
110. [110] Greenwood BM. Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. Lancet 1974;1:435-436.
111. [111] Lambert PH, Berney M, Kazyumba C. Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlation with polyclonal B cell activation and with intracerebral immunoglobulin synthesis. J Clin Invest 1981;57:77-85.
112. [112] Boreham PF. Autocoids: their release and possible role in the pathogenesis of African trypanosomiasis. In: Tizard I, editor. Immunology and pathogenesis of trypanosomiasis. Boca Raton, FL: CRC Press 1985;45-66.
113. [113] Nagle RB, Ward PA, Lindsley HB, et al. Experimental infections with African trypanosomiasis. VI. Glomerulonephritis involving the alternate pathway of complement activation. Am J Trop Med Hyg 1974;23:15-26.
114. [114] Galvao-Castro B.A, Hochmann A, Lambert PH. The role of the host immune response in the development of tissue lesions associated with African trypanosomiasis. Clin Exp Immunol 1978;33:12-24.
115. [115] Morrison WI, Murray M, McIntyre WIM. Bovine trypanosomiasis. In: Ristic M, McIntyre I, editors. Diseases of cattle in the tropics. The Hague: Martinus Nijhoff, 1981;469-497.
116. [116] Valli VEO, Forsberg CM. The pathogenesis of Trypanosoma congolense V. Quantitative histological changes. Vet Pathol 1979;16:334-368.
117. [117] Tedder TF, Inaoki M, Sato S. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 1997;6:107 118.
118. [118] Klaus GGB, Humphrey JH. A re-evaluation of the role of C3 in B-cell activation. Immunol Today 1986;7:163-165.
119. [119] Hebell T, Ahearn JM, Fearon DT. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 1991;254:102-105.
120. [120] Thyphronitis G, Kinoshita T, Inoue K, et al. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J Immunol 1991;147:224-230.
121. [121] Wiersma EJ, Kinoshita T, Heyman B. Inhibition of immunological memory and T-independent humoral responses by monoclonal antibodies specific for murine complement receptors. Eur J Immunol 1991;21:2501-2506.
122. [122] Dempsey PW, Allison MED, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996;271:348-350.
123. [123] Williams DJL, Naessens J, Scott JR, McOdimba FA. Analysis of peripheral leucocyte populations in N'Dama and Boran cattle following a rechallenge infection with Trypanosoma congolense. Parasite Immunol 1991;13:171-185.
124. [124] Scott JM, Pegram RG, Holmes PH, et al. Immunosuppression in bovine trypanosomiasis: field studies using foot-and-mouth disease vaccine and clostridial vaccine. Trop Anim Health Prod 1977;9:159-165.
125. [125] Rurangirwa RR, Tabel H, Losos G, Masiga WN, Mwambu P. Immunosuppressive effects of Trypanosoma congolense and Trypanosoma vivax on the secondary immune response of cattle to Mycoplasma mycoides subsp mycoides. Res Vet Sci 1978;25:395-397.
126. [126] Ilemobade AA, Adegboye DS, Onoviran O, Chima JC. Immunodepressive effects of trypanosomal infection in cattle immunized against contagious bovine pleuropneumonia. Parasite Immunol 1982;4:273-282.
127. [127] Mwangi DM, Munyua WK, Nyaga PN, Immunosuppression in caprine trypanosomiasis: effects of acute Trypanosoma congolense infection on antibody response to anthrax spore vaccine. Trop Anim Health Prod 1990;22:95-100.
128. [128] Fearon DT, Ahearn JM. Complement receptor Type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr Virus receptor; CD21). Curr Top Microbiol Immunol 1989;153:83-98.
129. [129] Cosio FG, Xiao-Ping S, Birmingham DJ, Van Aman M, Hebert LA. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J Immunol 1990;45:4198-4206.
130. [130] Herbert WJ, Inglis MD. Immunization of mice against Trypanosoma brucei infection by the administration of released antigen adsorbed to erythrocytes. Trans R Soc Trop Med Hyg 1973;67:268.
131. [131] Kobayashi A, Tizard IR, Woo PTK. Studies on the anaemia in experimental African trypanosomiasis. II. The pathogenesis of the anaemia in calves infected with Trypanosoma congolense. Am J Trop Med Hyg 1976;25:401-406.
132. [132] MacKenzie PKI, Boyt WP, Nesham VW, Pirie E. The aetiology and significance of the phagocytosis of erythrocytes and leucocytes in sheep infected with Trypanosoma congolense (Broden, 1904). Res Vet Sci 1978;24:4-7.
133. [133] Facer CA, Crosskey JM, Clarkson MJ, Jenkins GC. Immune haemolytic anaemia in bovine trypanosomiasis. J Comp Pathol 1982;92:393-401.
134. [134] Banks KL. In vitro binding of Trypanosoma congolense to erythrocytes. J Protozool 1979;26:103-108.
135. [135] Banks KL. Injury induced by Trypanosoma congolense adhesion to cell membranes. J Parasitol 1980;66:34-37.
136. [136] Howard CJ, Taylor G, Brownlie J. Surface receptors for immunoglobulin on bovine polymorphonuclear neutrophils and macrophages. Res Vet Sci 1980;29:128-130.
137. [137] Zhang G, Young JR, Tregaskes CR, Howard C. Cattle FeγRII: molecular cloning and ligand specificity. Immunogenetics 1994;39:423-427.
138. [138] McGuire TC, Musoke AJ, Kurtti T. Functional properties of bovine IgG1 and IgG2: interactions with complement, macrophages, neutrophils and skin. Immunology 1979;38:249-256.
139. [139] Fierer J, Askonas BA. Trypanosoma brucei infection stimulates receptor-mediated phagocytosis by murine peritoneal macrophages. Infect Immun 1982;37:1282-1284.
140. [140] Grosskinsky CM, Ezekowitz RAB, Berton G, Gordon S, Askonas BA, Macrophage activation in murine African trypanosomiasis. Infect Immun 1983;39:1080-1086.
141. [141] Kamanga-Sollo EIP, Musoke AJ, Nantulya VM, Rurangirwa FR, Masake RA. Differences between N'Dama and Boran cattle in the ability of their peripheral blood leucocytes to bind antibody-coated trypanosomes. Acta Trop 1991;49:109-117.
142. [142] Kissling K, Karbe E, Freitas EK. In vitro phagocytic activity of neutrophils of various cattle breeds with and without Trypanosoma congolense infection. Tropenmed Parasitol 1982;33:158-160.
143. [143] Balber AE, Bangs JD, Jones SM, Proia RL. Inactivation or elimination of potentially trypanolytic, complement-inactivating immune complexes by pathogenic trypanosomes. Infect Immun 1979;24:617-627.
144. [144] Frevert U, Reinwald E. Trypanosoma congolense blood-stream forms evade lysis in vitro by shedding of immune complexes. Eur J Cell Biol 1990;52:264-269.
145. [145] Shakibaei M, Frevert U. Cell surface interactions between Trypanosoma congolense and macrophages during phagocytosis in vitro. J Protozool 1992;39:224-235.
146. [146] Webster P, Russo DCW, Black SJ. The interaction of Trypanosoma brucei with antibodies to variant surface glycoproteins. J Cell Sci 1990;96:249-255.
147. [147] Russo DC, Grab DJ, Lonsdale-Eccles JD, Shaw MK, Williams DJL. Directional movement of variable surface glycoprotein-antibody complexes in Trypanosoma brucei. Eur J Cell Biol 1993;62:432-441.
148. [148] Ferrante A, Allison AC. Alternative pathway of complement activation by African trypanosomes lacking a glycoprotein coat. Parasite Immunol 1983;5:491-498.
149. [149] DeGee ALW, Mansfield JM. Genetics of resistance to the African trypanosomes IV. Resistance of radiation chimeras to Trypanosoma rhodesiense infection. Cell Immunol 1984;87:85-91.
150. [150] DeGee ALW, Levine RR, Mansfield JM. Genetics of resistance to the African trypanosomes VI. Heredity of resistance and variable surface glycoprotein-specific immune responses. J Immunol 1988;140:283-288.
151. [151] Ogunremi O, Tabel H. Genetics of resistance to Trypanosoma congolense in inbred mice: efficiency of apparent clearance of parasites correlates with long-term survival. J Parasitol 1995;81:876-881.
152. [152] Anosa VO, Kaneko JJ. Ultrastructural pathology of hemopoietic organs in Trypanosoma vivax infection of goats. Vet Pathol 1989;26:78-83.
153. [153] Anosa VO, Logan-Henfrey LL, Shaw M. A light and electron microscopic study of changes in blood and bone marrow in acute hemorrahagic Trypanosoma vivax infection in calves. Vet Pathol 1992;29:33-45.
154. [154] Rifkin MR, Landsberger FR. Trypanosome variant surface glycoprotein transfer to target membranes: a model for the pathogenesis of trypanosomiasis. Proc Natl Acad Sci U.S.A. 1990;87:801-805.
155. [155] Amole BO, Clarkson Jr AB, Shear HL. Pathogenesis of anemia in Trypanosoma brucei-mfected mice. Infect Immun 1982;36:1060-1068.
156. [156] Jenkins GC, Facer CA. Hematology of African trypanosomiasis. In: Tizard I, editor. Immunology and pathogenesis of trypanosomiasis. Boca Raton, FL: CRC Press, 1985;13-44.
157. [157] Murray M, Dexter TM. Anaemia in bovine African trypanosomiasis. Acta Trop 1988;45:389-432.
158. [158] Trail JCM, D'Ieteren GDM, Feron A, Kakiese O, Mulungo M, Peolo M. Effect of trypanosome infection, control of parasitaemia and control of anaemia development on productivity of N'Dama cattle. Acta Trop 1990;48:37-45.
159. [159] Trail JCM, D'Ieteren GDM, Colardelle C, et al. Evaluation of a field test for trypanotolerance in young N'Dama cattle. Acta Trop 1991;48:47-57.
160. [160] Paling RW, Moloo SK, Scott JR. The relationship between parasitaemia and anaemia in N'Dama and zebu cattle following four sequential challenges with Glossina morsitans centralis infected with Trypanosoma congolense. In: OAU/STRC, editor. Proceedings of the 19th Meeting of the International Scientific Council for Trypanosomiasis Research and Control, Nairobi. Nairobi: Eleza Services, 1988;256-264.
161. [161] Mansfield JM. Immunology of African trypanosomiasis. In: Wyler DG, editor. Modern parasite biology. New York: WH Freeman, 1989;222-246.
162. [162] Vickerman K, Myler PJ, Stuart KD. African trypanosomiasis. In: Warren KS, editor. Immunology and molecular biology of parasitic infections, 3rd edition. Boston, MA: Blackwell Scientific: 1993;171-212.
163. [163] Sileghem M., Flynn J.N., Darji A., De Baetselier P., Naessens J. African Trypanosomiasis. In: Kierszenbaum F, editor. Parasitic Infections and the Immune System. San Diego, CA: Academic Press, 1994; 1-51.
164. [164] De Baetselier P. Mechanisms underlying trypanosome-induced T-cell immunosuppression. In: Mustafa AS, Al-Attiyah RJ, Nath I, Chugh TD, editors. T-cell subsets and cytokines interplay in infectious diseases. Basle: S. Karger, 1996;124-139.
165. [165] Pinder M., Chassin P, Fumoux F. Mechanisms of self cure from Trypanosoma congolense infection in mice. J Immunol 1986;136:1427-1434.
166. [166] Kobayashi A, Tizard IR. Response to Trypanosoma congolense in calves Determination of immunoglobulins IgG1, IgG2, IgM and C3 levels and the complement fixing antibody titres during the course of infection. Tropenmed Parasitol 1976;27:411-417.
167. [167] Rurangirwa FR, Tabel H, Losos G, Tizard IR. Hemolytic complement and serum C3 levels in Zebu cattle infected with Trypanosoma congolense and Trypanosoma vivax and the effect of trypanocidal treatment. Infect Immun 1980;27:832-836.
168. [168] Tabel H, Losos GJ, Maxie MG. Experimental bovine trypanosomiasis (Trypanosoma vivax and T. congolense). II. Serum levels of total protein, albumin, hemolytic complement, and complement component C3. Tropenmed Parasitol 1980;31:99-104.
169. [169] Lutje V, Taylor KA, Kennedy D, Authié E, Boulangé A, Gettinby G. Trypanosoma congolense: a comparison of T-cell-mediated responses in lymph nodes of trypanotolerant and trypanosusceptible cattle during primary infection. Exp Parasitol 1996;84:320-329.
170. [170] Taylor KA, Lutje V, Mertens B. Nitric oxide synthesis is depressed in Bos indicus cattle infected with Trypanosoma congolense and T. vivax and does not mediate T cell suppression. Infect Immun 1996:64:4115-4122.
171. [171] Han S, Hathcock K. Zheng B, et al. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J Immunol 1995;155:556-567.
172. [172] Lutje V, Taylor KA, Boulangé A, Authié E. Tissue localisation of long-term T-cell and antibody responses to Trypanosoma congolense antigens in N'Dama cattle. Immunol Lett 1995;48:29-34.
173. [173] Flynn JN, Sileghem M, Williams DJL. Parasite-specific T-cell responses of trypanotolerant and trypanosusceptible cattle during infection with Trypanosoma congolense. Immunology 1992;75:639-645.
174. [174] Snapper CM, Paul WE. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987;236:944-947.
175. [175] King CL, Nutman TB. IgE and IgG subclass regulation by IL-4 and IFN-gamma in human helminth infections -assessment by B-cell precursor frequencies. J Immunol 1993;151:458-465.
176. 2 production from bovine B cells costimulated with anti-μ and mitogen. Cell Immunol 1994;154:287-295.
177. [177] Sileghem M, Hamers R, De Baetselier P. Active suppression of interleukin-2 secretion in mice infected with Trypanosoma brucei AnTat 1.1E. Parasite Immunol 1986;8:641-649.
178. [178] Sileghem M, Hamers R, De Baetselier P. Experimental Trypanosoma brucei infection selectively suppress both interleukin 2 production and interleukin-2 receptor expression. Eur J Immunol 1987;17:1417-1421.
179. + T cells suppresses growth of Trypanosoma brucei brucei and interferon-gamma production in infected rats. Clin Exp Immunol 1990;81:195-199.
180. + T cells: a trypanosome-released factor triggers interferon-γ production that stimulates parasite growth. Eur J Immunol 1991;21:2447-2454.
181. [181] Schleifer KW, Filutowicz H, Schof LR, Mansfield JM. Characterization of T helper cell responses to the trypanosome variant surface glycoprotein. J Immunol 1993;150:2910-2919.
182. [182] Sileghem M, Darji A, Kernels L, Hamers R, De Baetselier P. Different mechanisms account for the suppression of interleukin-2 production and the suppression of interleukin-2 receptor expression in Trypanosoma brucei-infected mice. Eur J Immunol 1989;19:825-835.
183. [183] Gajewski TJ, Schnell SR, Nav G, Fitch FW. Regulation of T-cell activation: differences among T-cell subsets. Immunol Rev 1989;111:79-110.
184. [184] McKernan LN, Blank KJ, Spitalny GL, Murasko DM. Inhibition of macrophage-induced antigen-specific T-cell proliferation by interferon-γ. Cell Immunol 1988;114:432-439.
185. [185] Darji A, Lucas R, Magez S, et al. Mechanisms underlying trypanosome-elicited immunosuppression. Ann Soc Belge Med Trop 1992;72:27-38.
186. [186] Sternberg J, McGuigan F. Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection. Eur J Immunol 1992;22:2741-2744.
187. [187] Schleifer KW, Mansfield JM. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J Immunol 1993;151:5492-5503.
188. [188] Sternberg J, Mabbott N, Sutherland I, Liew FY. Inhibition of nitric oxide synthesis leads to reduced parasitemia in murine Trypanosoma brucei infection. Infect Immun 1994;62:2135-2137.
189. [189] Mabbott N, Sternberg J. Bone marrow nitric oxide production and development of anemia in Trypanosoma brucei-infected mice. Inf Immun 1995;63:1563-1566.
190. [190] DeGee AL, Sonnefeld G, Mansfield JM. Genetics of resistance to the African trypanosomes V. Qualitative and quantitative differences in interferon production among susceptible and resistant mouse strains. J Immunol 1985;134:2723-2726.
191. [191] Mansfield JM. T-cell responses to the trypanosome variant surface glycoprotein: a new paradigm? Parasitol Today 1994;10:267-270.
192. [192] Sternberg J, Mabbott JM. Nitric oxide-mediated suppression of T cell responses during Trypanosoma brucei infection: soluble trypanosome products and interferon-γ are synergistic inducers of nitric oxide synthesis. Eur J Immunol 1996;26:539-543.
193. [193] Paulnock CM, Smith C, Mansfield JM, Antigen presenting cell function in African trypanosomiasis. In: Schook LB, Tew JG, editors. Antigen presenting cells: diversity, differentiation, and regulation. New York: Alan R. Liss, 1988;135-143.
194. [194] Mitchell LA, Pearson TW, Gauldie J. Interleukin-1 and interleukin-2 production in resistant and susceptible inbred mice infected with Trypanosoma congolense. Immunology 1986;57:291-296.
195. + macrophages and associated immunosuppression in African trypanosomiasis. Infect Immun 1981;32:188-193.
196. [196] Sileghem M, Darji A, Hamers R, De Baetselier P. Modulation of IL-1 production and IL-1 release during experimental trypanosome infections. Immunology 1989;68:137-139.
197. [197] Flynn JN, Sileghem M. The role of the macrophage in induction of immunosuppression in Trypanosoma congolense-infected cattle. Immunology 1991;74:310-316.
198. [198] Lutje V, Mertens B, Boulangé A, Williams DJL, Authié E. Trypanosoma congolense: proliferative responses and interleukin production in lymph node cells of infected cattle. Exp Parasitol 1995;81:154-164.
199. [199] Sileghem M, Flynn JN. Suppression of T-cell responsiveness during tsetse-transmitted trypanosomiasis in cattle. Scand J Immunol 1992; 36(Suppl 11): 37-40.
200. [200] Sileghem M, Flynn JN, Logan-Henfrey L, Ellis J. Tumor necrosis factor production by monocytes from cattle infected with Trypanosoma (Duttonella) vivax and Trypanosoma (Nannomonas) congolense: possible association with severity of anaemia associated with the disease. Parasite Immunol 1994;16:51-54.
201. [201] Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mossman TR. Interleukin-10. Annu Rev Immunol 1993;11:165-190.
202. [202] de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
203. [203] Fiorentino DF, Zlotnik A, Mossman TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-3822.
204. [204] Kennedy MK, Picha KS, Shaneveck KD, Anderson DM, Grabstein KH. Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones. Eur J Immunol 1994;24:2271-2278.
205. [205] Willems F, Marchant A, Delville JP, et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994;24:1007-1009.
206. [206] Dubois PM, Andris F, Shapiro RA, et al. T cell long-term hyporesponsiveness follows antigen receptor engagement and results from defective signal transduction. Eur J Immunol 1994;24:348-354.
207. [207] Jenkins MJ, Chen C, Jung G, Mueller DL, Schwartz RH. Inhibition of antigen-specific proliferation of Type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol 1990;140:16-22.
208. [208] King CL, Mahanty S, Kumaraswami V, et al. Cytokine control of parasite-specific anergy in human lymphatic filariasis. J Clin Invest 1993;92:1667-1673.
209. [209] King CL, Medhat A, Malhotra I, et al. Cytokine control of parasite-specific anergy in human urinary schistosomiasis, IL-10 modulates lymphocyte reactivity. J Immunol 1996;156:4715-4721.
210. [210] Ghalib HW, Piuvezam MR, Skeiky YA, et al. Interleukin 10 production correlates with pathology in human Leishmania donovani. J Clin Invest 1993;92:324-329.
211. [211] Candolfi E, Hunter CA, Remington JS. Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis. Infect Immun 1995;63:751-756.
212. [212] Meyaard L, Schuitemaker H, Miedema F. T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function. Immunol Today 1993;14:161-164.
213. [213] Clerici M, Wynn TA, Berzofsky JA, et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994;93:768-775.
214. [214] Sieling PA, Abrams JS, Yamamura M, et al. Immunosuppressive roles for IL-10 and IL-4 in human infection. J Immunol 1993;150:5501-5510.
215. [215] Chitko-McKown CG, Ruef BJ, Rice-Ficht AC, Brown WC. Interleukin-10 downregulates proliferation and expression of interleukin-2 receptor p55 chain and interferon-γ, but not interleukin-2 or interleukin-4, by parasite-specific helper T cell clones obtained from cattle chronically infected with Babesia bovis or Fasciola hepatica. J Interferon Cytokine Res 1995;15:915-922.
216. + B cells in normal and Trypanosoma congolense-infected cattle. Eur J Immunol 1992;22:1713-1718.
217. [217] O'Garra A, Howard M. Cytokines and Ly-1 (B1) B cells. Int Rev Immunol 1992;8:219-234.
218. [218] Agyemang K, Dwinger RH, Jeanin P, et al. Biological and economic impact of trypanosome infections on milk production in N'Dama cattle managed under village conditions in The Gambia. Anim Prod 1990;50:383-389.
219. + T cells and accompanied by over-production of IL-12, IFN-γ, and TNF-α. J Immunol 1996;157:798-805.
220. [220] Flores-Villanueva PW, Zheng XX, Strom TB, Stadecker JJ. Recombinant IL-10 and IL-10/Fc treatment down-regulate egg antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis. J Immunol 1996;156:3315-3320.
221. [221] Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG. Interleukin 10 and interferon γ regulation of experimental Trypanosoma cruzi infection. J Exp Med 1992;175:169-174.
222. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci U.S.A. 1991;88:7011-7015.
223. [223] Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J Immunol 1992;148:1792-1796.
224. [224] Romani L, Puccetti P, Mencacci A, et al. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol 1994;152:3514-3521.